查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508660

骨誘導再生市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Guided Bone Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 302 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於引導骨再生 (GBR) 市場的綜合報告。該報告對關鍵市場動態進行了深入分析，並對影響市場前景的驅動因素、趨勢、機會和課題提供了見解。

關鍵見解

  • 引導骨再生市場規模（2024 年）：7.914 億美元
  • 預計市值（2033 年）：12 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：4.7%

骨引導再生市場 - 研究範圍：

引導骨再生（GBR）技術透過促進局部缺損的骨組織再生，在再生牙科和骨科中發揮重要作用。這些技術使用屏障膜和骨移植材料來創造適合骨骼生長的空間並恢復骨量和結構。 GBR 市場為牙科診所、醫院和骨科中心提供服務，為各種臨床應用提供各種生物材料、薄膜和手術器械。

推動市場成長的因素：

全球引導骨再生市場受到多種因素的推動，包括牙周病患病率的增加、創傷和疾病導致的骨缺損發生率的上升以及更容易患骨相關疾病的老齡化人口的增加。因素。生物材料、膜設計和微創手術技術的技術進步正在提高治療效果和患者康復並推動市場擴張。此外，GBR技術的應用範圍從牙科和骨科專業領域擴展到顏面外科和獸醫學，正在為市場參與者創造新的成長機會。

市場限制因素：

儘管成長前景廣闊，但骨誘導再生醫學市場面臨治療成本高、報銷範圍有限以及生物材料和醫療器材的審批和商業化監管複雜性等問題。嚴格的監管要求和區域醫療保健政策給製造商和醫療保健提供者帶來了合規負擔，影響了市場滲透和業務策略。

市場機會：

由於新興經濟體持續的研發活動、策略聯盟和不斷擴大的醫療基礎設施，骨引導再生醫學市場提供了巨大的成長機會。生物相容性材料、客製化植體的 3D 列印技術和數位牙科解決方案的創新提高了治療準確性和患者治療效果，刺激了市場需求。此外，遠距醫療平台和數位醫療技術的整合有利於遠距患者監測和術後護理管理，提高治療依從性和臨床結果。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏事項·除外事項

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 開發趨勢

第4章 主要內容

  • 產品採用分析:各地區
  • 產品的USP分析
  • 主要的推銷策略:各製造廠商
  • 法規情勢
  • 大環境分析
  • 波特分析
  • 價值鏈分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素 - 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • 2024年的市場情勢
  • COVID-19及影響分析
    • 各材料
    • 各用途
    • 各終端用戶
    • 各地區

第7章 全球骨誘導再生市場需求(數量)分析

  • 過去的市場數量分析，2019年～2023年
  • 現在及未來市場數量預測，2024年～2033年
    • 與前一年同期比較成長趨勢分析

第8章 全球骨誘導再生市場 - 價格分析

  • 各地區價格分析:各材料
  • 價格的明細
    • 廠商層級
    • 分銷商層級
  • 世界平均價格分析基準
  • 價格設定的前提條件

第9章 全球骨誘導再生市場需求(金額或規模，一百萬美元)分析

  • 過去的市場金額(一百萬美元)分析，2019年～2023年
  • 現在及未來市場金額(一百萬美元)預測，2024年～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第10章 全球骨誘導再生市場分析:各材料

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)和數量的分析:各材料，2019年～2023年
  • 現在及未來市場規模(一百萬美元)和數量的分析與預測:各材料，2024年～2033年
    • 骨移植替代品
    • 阻障薄膜
  • 市場魅力分析:各材料

第11章 全球骨誘導再生市場分析:各用途

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各用途，2019年～2023年
  • 現在及未來市場規模(一百萬美元)的分析與預測:各用途，2024年～2033年
    • 植入學
    • 牙周病學
    • 口腔外科
    • 其他
  • 市場魅力分析:各用途

第12章 全球骨誘導再生市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各終端用戶，2019～2023年
  • 現在及未來市場規模(一百萬美元)的分析與預測:各終端用戶，2024年～2033年
    • 醫院
    • 牙科醫院
    • 學術研究中心
    • 門診病人手術中心
  • 市場魅力分析:各終端用戶

第13章 全球骨誘導再生市場分析:各地區

  • 簡介
  • 過去的市場規模(一百萬美元)和數量的分析:各地區，2019年～2023年
  • 現在及未來市場規模(一百萬美元)和數量的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東·非洲
  • 市場魅力分析:各地區

第14章 北美的骨誘導再生市場分析

第15章 南美的骨誘導再生市場分析

第16章 歐洲的骨誘導再生市場分析

第17章 南亞的骨誘導再生市場分析

第18章 東亞的骨誘導再生市場分析

第19章 大洋洲的骨誘導再生市場分析

第20章 中東·非洲(MEA)的骨誘導再生市場分析

第21章 市場結構分析

  • 市場分析:各級企業
  • 主要企業的市場佔有率分析
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭的詳細資訊
    • Baxter International Inc.
    • Medtronic
    • Stryker Corp.
    • Integra LifeSciences
    • Zimmer Biomet Holdings
    • Dentsply Sirona
    • botiss biomaterials GmbH
    • Geistlich Pharma AG
    • Biotech Dental
    • Dentegris GmbH
    • GENOSS Co.,Ltd.
    • Osstem Implant

第23章 所使用的前提條件與縮寫

第24章 調查手法

簡介目錄
Product Code: PMRREP32985

Persistence Market Research has recently released a comprehensive report on the Guided Bone Regeneration (GBR) market. The report provides an in-depth analysis of crucial market dynamics, offering insights into drivers, trends, opportunities, and challenges shaping the market landscape.

Key Insights:

  • Guided Bone Regeneration Market Size (2024E): USD 791.4 million
  • Projected Market Value (2033F): USD 1,200.00 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.7%

Guided Bone Regeneration Market - Report Scope:

Guided Bone Regeneration (GBR) techniques play a critical role in regenerative dentistry and orthopedic surgery by facilitating the regeneration of bone tissue in localized defects. These techniques involve the use of barrier membranes and bone graft materials to create a space conducive to bone growth, thereby restoring bone volume and architecture. The GBR market serves dental clinics, hospitals, and orthopedic centers, offering a variety of biomaterials, membranes, and surgical instruments tailored for different clinical applications.

Market Growth Drivers:

The global Guided Bone Regeneration market is driven by several factors, including increasing prevalence of periodontal diseases, rising incidence of bone defects due to trauma or disease, and growing aging population susceptible to bone-related disorders. Technological advancements in biomaterials, membrane designs, and minimally invasive surgical techniques enhance treatment outcomes and patient recovery, fostering market expansion. Moreover, expanding applications of GBR techniques beyond dental and orthopedic specialties into maxillofacial surgery and veterinary medicine create new growth opportunities for market players.

Market Restraints:

Despite promising growth prospects, the Guided Bone Regeneration market faces challenges related to high treatment costs, limited reimbursement coverage, and regulatory complexities governing the approval and commercialization of biomaterials and medical devices. Stringent regulatory requirements and varying healthcare policies across regions impose compliance burdens on manufacturers and healthcare providers, influencing market penetration and operational strategies.

Market Opportunities:

The Guided Bone Regeneration market presents significant growth opportunities driven by ongoing research and development activities, strategic collaborations, and expanding healthcare infrastructure in emerging economies. Innovations in biocompatible materials, 3D printing technologies for customized implants, and digital dentistry solutions enhance treatment precision and patient outcomes, stimulating market demand. Furthermore, the integration of telemedicine platforms and digital health technologies facilitates remote patient monitoring and post-operative care management, improving treatment adherence and clinical outcomes.

Competitive Intelligence and Business Strategy:

Leading players in the global Guided Bone Regeneration market, such as Medtronic,Stryker Corp.,Integra LifeSciences, focus on product innovation, strategic partnerships, and market expansion initiatives to maintain competitive advantage. These companies invest in R&D to develop advanced biomaterials, biodegradable membranes, and patient-specific surgical kits, addressing diverse clinical needs and enhancing treatment efficacy. Collaborations with academic institutions, dental research centers, and regulatory agencies support technology adoption and market access, driving sustainable growth in the dynamic GBR landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Guided Bone Regeneration market globally?
  • Which biomaterials and membrane technologies are driving adoption of GBR techniques across dental and orthopedic specialties?
  • How are technological advancements reshaping the competitive landscape of the Guided Bone Regeneration market?
  • Who are the key players contributing to the Guided Bone Regeneration market, and what strategies are they employing to sustain market leadership?
  • What are the emerging trends and future prospects in the global Guided Bone Regeneration market?

Key Companies Profiled

  • Baxter International Inc.
  • Medtronic
  • Stryker Corp.
  • Integra LifeSciences
  • Zimmer Biomet Holdings
  • Dentsply Sirona
  • botiss biomaterials GmbH
  • Geistlich Pharma AG
  • Biotech Dental
  • Dentegris GmbH
  • GENOSS Co., Ltd.
  • Osstem Implant

Guided Bone Regeneration Industry Research Segmentation

By Material:

  • Bone Graft Substitutes
  • Barrier Membranes

By Application:

  • Implantology
  • Periodontology
  • Oral and Maxillofacial Surgery

By End User:

  • Hospitals
  • Dental Clinics
  • Academic & Research Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion And Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development Trends

4. Key Inclusions

  • 4.1. Product Adoption Analysis by Region
  • 4.2. Product USP Analysis
  • 4.3. Key Promotional Strategies by Manufacturers
  • 4.4. Regulatory Scenario
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
    • 5.1.3. Global Bone Regeneration Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Increasing Prevalence of Dental Diseases
    • 5.2.3. Adoption of Minimally Invasive Procedures
    • 5.2.4. Increasing Prevalence of Bone Related disorders
    • 5.2.5. New Product launches and approvals
    • 5.2.6. Regulatory Policies
    • 5.2.7. Historic and Current Revenue of key players
    • 5.2.8. Technology advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Material
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Region

7. Global Guided Bone Regeneration Market Demand (Volume) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Guided Bone Regeneration Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Material
  • 8.2. Pricing Break Up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Guided Bone Regeneration Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Material

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Material, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Material, 2024-2033
    • 10.3.1. Bone Graft Substitutes
      • 10.3.1.1. Allograft
      • 10.3.1.2. Xenograft
      • 10.3.1.3. Synthetic Bone Graft
      • 10.3.1.4. Others
    • 10.3.2. Barrier Membrane
      • 10.3.2.1. Expanded polytetrafluoroethylene (e-PTFE)
      • 10.3.2.2. High-density polytetrafluoroethylene (d-PTFE)
      • 10.3.2.3. Titanium mesh and titanium-reinforced PTFE
  • 10.4. Market Attractiveness Analysis By Material

11. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 11.3.1. Implantology
    • 11.3.2. Periodontology
    • 11.3.3. Oral and Maxillofacial surgery
    • 11.3.4. Others
  • 11.4. Market Attractiveness Analysis By Application

12. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Dental Clinics
    • 12.3.3. Academic & Research Centers
    • 12.3.4. Ambulatory Surgical Centers
  • 12.4. Market Attractiveness Analysis By End User

13. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units)Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa
  • 13.4. Market Attractiveness Analysis By Region

14. North America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Material
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Material
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Guided Bone Regeneration Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Material
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Guided Bone Regeneration Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Material
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By End User

15. Latin America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Material
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Material
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Guided Bone Regeneration Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Material
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By End User
    • 15.7.2. Mexico Portable Multi-Parameter Monitors Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Material
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Guided Bone Regeneration Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Material
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By End User

16. Europe Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Nordic Countries
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Material
    • 16.3.3. By Portability
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Material
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Guided Bone Regeneration Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Material
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Guided Bone Regeneration Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Material
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By End User
    • 16.7.3. France Guided Bone Regeneration Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Material
        • 16.7.3.2.2. By Application
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Guided Bone Regeneration Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Material
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Guided Bone Regeneration Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Material
        • 16.7.5.2.2. By Application
        • 16.7.5.2.3. By End User
    • 16.7.6. BENULUX Guided Bone Regeneration Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Material
        • 16.7.6.2.2. By Application
        • 16.7.6.2.3. By End User
    • 16.7.7. Russia Guided Bone Regeneration Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Material
        • 16.7.7.2.2. By Application
        • 16.7.7.2.3. By End User
    • 16.7.8. Nordic Countries Guided Bone Regeneration Market
      • 16.7.8.1. Introduction
      • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.8.2.1. By Material
        • 16.7.8.2.2. By Application
        • 16.7.8.2.3. By End User

17. South Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Material
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Material
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Guided Bone Regeneration Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Material
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By End User
    • 17.7.2. Indonesia Guided Bone Regeneration Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Material
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By End User
    • 17.7.3. Malaysia Guided Bone Regeneration Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Material
        • 17.7.3.2.2. By Application
        • 17.7.3.2.3. By End User
    • 17.7.4. Thailand Guided Bone Regeneration Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Material
        • 17.7.4.2.2. By Application
        • 17.7.4.2.3. By End User

18. East Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Material
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Material
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Guided Bone Regeneration Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Material
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By End User
    • 18.7.2. Japan Guided Bone Regeneration Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Material
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By End User
    • 18.7.3. South Korea Guided Bone Regeneration Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Material
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By End User

19. Oceania Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Material
    • 19.3.3. By Application
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Material
    • 19.4.3. By Application
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Guided Bone Regeneration Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Material
        • 19.7.1.2.2. By Application
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Guided Bone Regeneration Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Material
        • 19.7.2.2.2. By Application
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Material
    • 20.3.3. By Application
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Material
    • 20.4.3. By Application
    • 20.4.4. By End User
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Guided Bone Regeneration Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Material
        • 20.7.1.2.2. By Application
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkey Guided Bone Regeneration Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Material
        • 20.7.2.2.2. By Application
        • 20.7.2.2.3. By End User
    • 20.7.3. North Africa Guided Bone Regeneration Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Material
        • 20.7.3.2.2. By Application
        • 20.7.3.2.3. By End User
    • 20.7.4. South Africa Guided Bone Regeneration Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Material
        • 20.7.4.2.2. By Application
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis
    • 21.3.1. Regional footprint of Players
    • 21.3.2. Material footprint by Players
    • 21.3.3. Channel footprint by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Baxter International Inc.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Key Developments
      • 22.3.1.7. Strategy Overview
        • 22.3.1.7.1. Channel Strategy
        • 22.3.1.7.2. Marketing Strategy
        • 22.3.1.7.3. Material Strategy
    • 22.3.2. Medtronic
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Key Developments
      • 22.3.2.7. Strategy Overview
        • 22.3.2.7.1. Channel Strategy
        • 22.3.2.7.2. Marketing Strategy
        • 22.3.2.7.3. Material Strategy
    • 22.3.3. Stryker Corp.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Key Developments
      • 22.3.3.7. Strategy Overview
        • 22.3.3.7.1. Channel Strategy
        • 22.3.3.7.2. Marketing Strategy
        • 22.3.3.7.3. Material Strategy
    • 22.3.4. Integra LifeSciences
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Key Developments
      • 22.3.4.7. Strategy Overview
        • 22.3.4.7.1. Channel Strategy
        • 22.3.4.7.2. Marketing Strategy
        • 22.3.4.7.3. Material Strategy
    • 22.3.5. Zimmer Biomet Holdings
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Key Developments
      • 22.3.5.7. Strategy Overview
        • 22.3.5.7.1. Channel Strategy
        • 22.3.5.7.2. Marketing Strategy
        • 22.3.5.7.3. Material Strategy
    • 22.3.6. Dentsply Sirona
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Key Developments
      • 22.3.6.7. Strategy Overview
        • 22.3.6.7.1. Channel Strategy
        • 22.3.6.7.2. Marketing Strategy
        • 22.3.6.7.3. Material Strategy
    • 22.3.7. botiss biomaterials GmbH
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Key Developments
      • 22.3.7.7. Strategy Overview
        • 22.3.7.7.1. Channel Strategy
        • 22.3.7.7.2. Marketing Strategy
        • 22.3.7.7.3. Material Strategy
    • 22.3.8. Geistlich Pharma AG
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Key Developments
      • 22.3.8.7. Strategy Overview
        • 22.3.8.7.1. Channel Strategy
        • 22.3.8.7.2. Marketing Strategy
        • 22.3.8.7.3. Material Strategy
    • 22.3.9. Biotech Dental
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Key Developments
      • 22.3.9.7. Strategy Overview
        • 22.3.9.7.1. Channel Strategy
        • 22.3.9.7.2. Marketing Strategy
        • 22.3.9.7.3. Material Strategy
    • 22.3.10. Dentegris GmbH
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Key Developments
      • 22.3.10.7. Strategy Overview
        • 22.3.10.7.1. Channel Strategy
        • 22.3.10.7.2. Marketing Strategy
        • 22.3.10.7.3. Material Strategy
    • 22.3.11. GENOSS Co.,Ltd.
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Key Developments
      • 22.3.11.7. Strategy Overview
        • 22.3.11.7.1. Channel Strategy
        • 22.3.11.7.2. Marketing Strategy
        • 22.3.11.7.3. Material Strategy
    • 22.3.12. Osstem Implant
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Key Developments
      • 22.3.12.7. Strategy Overview
        • 22.3.12.7.1. Channel Strategy
        • 22.3.12.7.2. Marketing Strategy
        • 22.3.12.7.3. Material Strategy

23. Assumptions and Acronyms Used

24. Research Methodology